Summary
3-EtO-PCP is a novel arylcyclohexylamine with an ethoxy substituent at the 3-position of the phenyl ring, making it a heavier and more lipophilic analogue of 3-MeO-PCP. User reports suggest strong dissociation with a sedating, muddy headspace more similar to DCK than the manic clarity of 3-MeO-PCP. Insufflation causes severe nasal pain and prolonged throat irritation; oral or sublingual administration is recommended. Due to its novelty, no peer-reviewed pharmacokinetic data exists. By structural analogy to other PCP derivatives, tolerance develops rapidly, cross-tolerance occurs with all dissociatives, and reagent testing plus ideally GC-MS confirmation is essential before use.
Dose Information
Light
Common
Strong
Heavy
Onset, Duration & After-effects
| ROA | Onset | Peak | Offset | After Effects |
|---|---|---|---|---|
| Oral | 30-45 min | 1-3 hrs | 2-4 hrs | 4-8 hrs |
| Insufflated | 10-20 min | 1-3 hrs | 2-4 hrs | 4-8 hrs |
| Vaporized / Smoked | 1-5 min | 1-2 hrs | 2-3 hrs | 4-8 hrs |
Tolerance
Build-up
develops with repeated use over days to weeks
Reset
2–4 weeks for noticeable reduction
Effects
Positive
- Pain relief
- Residual stimulation
- Physical euphoria
- Stimulation
Negative
- Nystagmus
- Numbness
- Loss of balance
- Nausea
- Sedation
- Physical disconnection
Positive
- Cognitive euphoria
- Conceptual thinking
Negative
- Depersonalization
- Derealization
- Motor control loss
- Thought deceleration
- Memory suppression
- Amnesia
- Dissociative anesthesia
- Time distortion
Positive
- Increased music appreciation
- Tactile enhancement
Negative
- Spatial disorientation
- Tactile suppression
- Derealization
- Disinhibition
- Double vision
- Pattern recognition suppression
- Visual disconnection
- Auditory distortion